BridgeMD
New treatment option for Substance Use
Official title A Randomized Clinical Trial of a Novel Drug Education and Diversion Program (iDECIDE) for Middle and High School Students
ClinicalTrials.gov ID: NCT06115746
What this study is testing
- What it's testing
- The primary goal of this study is to test the effectiveness of the iDECIDE (Drug Education Curriculum: Intervention, Diversion, and Empowerment) curriculum, a novel drug education and diversion program, in approximately 300 middle and high school students, who have violated their school substance use policies in the past month, as an alternative to punitive school responses for school-based substance use infractions. This randomized controlled trial will test the hypothesis that adolescents randomized to the iDECIDE curriculum will have improved substance use outcomes (i.e., knowledge, attitudes, and behavior) compared to adolescents in a waitlist control group.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 9 to 22
You may be able to join if
- Currently enrolled in middle or high school;
- Violated school substance use policy within approximately the past month at the time of screening;
- Have a parent or legal guardian who is able and willing to provide written informed consent (if under the age of 18);
- Competent and willing to provide written informed assent (if under the age of 18) or written informed consent (if age 18 or older);
- Able to commit to 9 study visits over approximately one year;
You likely can't join if
- Ever received substance use treatment in an inpatient or specialty care setting;
- Ever engaged in intravenous (IV) drug use;
- Current daily use of alcohol, non-medical benzodiazepines, and/or opioid use.
See the full eligibility criteria
- Currently enrolled in middle or high school;
- Violated school substance use policy within approximately the past month at the time of screening;
- Have a parent or legal guardian who is able and willing to provide written informed consent (if under the age of 18);
- Competent and willing to provide written informed assent (if under the age of 18) or written informed consent (if age 18 or older);
- Able to commit to 9 study visits over approximately one year;
- Able to safely participate in the protocol and appropriate for outpatient level of care, in the opinion of the investigator;
- Has access to a reliable internet connection and a device that can run Zoom;
- Able to read and write comfortably in one of the languages spoken by study staff.
- Ever received substance use treatment in an inpatient or specialty care setting;
- Ever engaged in intravenous (IV) drug use;
- Current daily use of alcohol, non-medical benzodiazepines, and/or opioid use.
The study team makes the final eligibility decision.
Where it's taking place
- Boston, Massachusetts, United States
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 9 years to 22 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Boston, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.